Cevimeline
- Level
- Commodity
- Parent
- 51151500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51151517This classification denotes a cholinergic agonist with the molecular formula C10H17NOS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K9V0CDQ56E, chemically known as 2-methyspiro(1,3-oxathiolane-5,3)quinuclidine but generally known as cevimeline, which bears US NIH Compound Identifier 83898. European Medicines Agency schedules Cevimeline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07461MIG. The term CEVIMELINE is an International Non-Proprietary Name. World Health Organization schedules cevimeline in its Anatomical Therapeutic Chemical (ATC) Classification. CEVIMELINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cevimeline under HS 29349990 and SITC 51579. As of Q4 2014, CEVIMELINE remains the US FDA Preferred Term for this commodity. Cevimeline bears US NLM identifiers UMLS ID C0093437 and NCI Concept Code C66873. SMILES: CC1OC2(CN3CCC2CC3)CS1.
Same parent
Under 51151500 · 44Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.